Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06423625 · ClinicalTrials.gov registry record
Hemorrhagic MI Prediction Score Model
A clinical trial, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 252
- Enrollment target
NCT06423625: Completed study, sponsored by Rohan Dharmakumar.
NCT06423625 is a clinical trial that has completed, run by Rohan Dharmakumar. The registered enrollment target is 252 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06423625 has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 252 participants
- Enrollment target
Study Summary
Developing a prediction score model for predicting the likelihood of Hemorrhagic MI
Primary Outcome
Percentage of MI patients confirmed as Hemorrhagic MI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-12-20 |
What the finished NCT06423625 record still lists
NCT06423625 is an observational study that tracks outcomes without assigning an intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06423625 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06423625 about?
NCT06423625 is a clinical study titled "Hemorrhagic MI Prediction Score Model". Developing a prediction score model for predicting the likelihood of Hemorrhagic MI
What is the current status of trial NCT06423625?
This trial is currently completed. The enrollment target is 252 participants. The study started on 2023-06-01. Estimated completion is 2025-12-20.
Who is sponsoring clinical trial NCT06423625?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI